Revolution of India’s Biotech Technology

Context 

Recently, the Indian Government has approved the BioE3 (Biotechnology for Economy, Environment and Employment) proposal to boost manufacturing in the biotechnology sector. India in recent times has taken significant steps in areas like vaccine development but it has still to fully capitalize on the broader potential of biotechnology.

The BioE3 policy focuses on six verticals, including bio-based chemicals, functional foods, precision biotherapeutics, climate-resilient agriculture, carbon capture, and marine/space research. While well-intentioned, the policy’s success depends on long-term financial and infrastructural support from both the central and state governments.

Significance of Biotech Sector in India

• Economic Powerhouse – The Biotechnology industry in India is slated to move towards explosive growth which is projected to reach USD 150 billion by 2025.
• Vaccine Prowess – India’s prowess in vaccine production has earned it the moniker “pharmacy of the world.” India accounts for 60% of global vaccine production, contributing 40-70% of the WHO demand for Diphtheria, Tetanus and Pertussis (DPT).
• Agricultural Revolution 2.0 – Biotechnology offers solutions to India’s pressing agricultural challenges, from climate-resilient crops to enhanced nutritional content. Bt cotton, India’s first genetically modified crop, now accounts for 95% of cotton cultivation, significantly increasing yields and farmer incomes.
• Environmental Safeguard – India’s environmental and climate change challenges can be effectively dealt with promising solutions offered by the Biotechnology industry. Bioremediation techniques are being developed to clean up polluted sites, with successful pilot projects like the cleaning of Versova Beach in Mumbai. The government’s push for climate-resilient agriculture under BioE3 could be a game-changer in adapting to climate change impacts.
• Innovation Ecosystem – India’s biotech sector is fostering a vibrant innovation ecosystem. The country now boasts over 5,000 biotech startups, with hubs like Bangalore Bioinnovation Centre and Hyderabad’s Genome Valley driving research and commercialization.
• Self-Reliance in Critical Sectors – Biotechnology is key to reducing India’s import dependence in critical sectors. Environmental biotechnology aids in creating eco-friendly alternatives to imported plastics and developing efficient waste management solutions.

Challenges hindering Growth of Biotechnology Sector in India

• Regulatory Issues – Biotech innovations in India are hampered by complex and slow regulatory processes. For instance, the approval of GMOs is very complex and cumbersome. The moratorium on Bt brinjal since 2010 serves as a prime example.
• Capital Crunch – Despite government initiatives, access to adequate funding remains a major hurdle for Indian biotech firms. Long gestation periods and high risks associated with biotech research deter many investors.
• Infrastructure Inadequacies – India’s Biotech infrastructure lags behind global standards in many areas despite recent improvements. The lack of reliable cold chain infrastructure poses challenges for pharmaceutical distribution, as highlighted during the Covid-19 vaccine rollout.
• Intellectual Property Insecurity – Intellectual property protection remains a concern for biotech innovators in India. Patent application filing increased by 24.64%, from 66440 in 2021-22 to 80211 in 2022-23, still enforcement challenges persist.
• Competing in Established Market – Indian Biotech firms face tough competition from already well-established global players, particularly in lucrative markets like biopharmaceuticals. Breaking into these markets requires not just innovative products but also significant investments in clinical trials, regulatory compliance, and marketing.
• Ethical Challenges – Biotechnology often intersects with complex ethical issues, creating roadblocks to research and commercialization. The ongoing debate over genetically modified crops exemplifies this, with public opposition stalling the introduction of GM mustard despite regulatory approvals.

Measures to Enhance Biotechnology Sector in India

• Streamlining of Regulatory Framework – India should establish a single-window clearance system for biotech projects, similar to the successful model used in the IT sector. This could be achieved by creating a unified Biotechnology Regulatory Authority of India (BRAI), consolidating the functions of multiple existing agencies.
• Innovative Funding Mechanism – India should look to create a dedicated Biotechnology Investment Fund by using a public-private partnership model. This fund could offer a mix of grants, soft loans, and equity investments tailored to different stages of biotech development.
• Transformation of Talent – A National Biotechnology Skill Development Program should be established to focus on emerging areas like synthetic biology, bioinformatics and precision medicine. Mandate industry internships as part of biotech curricula and incentivize companies to offer these opportunities.
• Building Adequate Infrastructure – Develop a network of shared high-end research facilities across the country, accessible to both academia and industry on a pay-per-use basis. Establish specialized biotech manufacturing zones with plug-and-play facilities, streamlined approvals, and shared utilities to reduce setup costs for companies.
• Make-in-India Biotech Manufacturing – Expand the Production Linked Incentive (PLI) scheme to cover a wider range of biotechnology products, including enzymes, bioplastics, and biofortified crops. This aligns with the Make in India initiative and addresses the BioE3 policy’s focus on boosting domestic manufacturing.

Conclusion

India’s potential in the Biotech sector can be enhanced further with the introduction of BioE3 Initiative. It has the potential to drive economic growth, take care of environmental sustainability and generate employment as well. But the success of all these objectives depends on the effective implementation of the Initiative and collaboration between the central and state governments. By leveraging regulatory complexities the BioE3 Initiative can easily overcome all the existing challenges in the biotech Industry.

SOURCE: The Hindu

Download as PDF